Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Objectives To investigate the effect of Benson relaxation response technique (BRRT) on the quality of life (QOL) among patients with systemic lupus erythematous (SLE). Methodology A quasi-experimental ...

Another older case report indicates that people with lupus panniculitis may have mild or no systemic symptoms. Scientists do not yet know the exact cause of lupus panniculitis. It could occur due ...

Chilblain lupus erythematosus (CHLE) is a rare type of cutaneous lupus erythematosus (CLE). Symptoms, such as lesions and swelling ... are unlikely to develop systemic lupus erythematosus ...

More information: Shutaro Shibata et al, Green tea consumption and cerebral white matter lesions in community-dwelling older adults without dementia, npj Science of Food (2025). DOI: 10.1038 ...

A new study links drinking green tea with having fewer white matter lesions in the brains of Japanese seniors, potentially providing a level of protection against dementia. Researchers from ...

Additional testing in the evaluation of lupus patients with NPSLE includes ... should be obtained to determine the subtle but common lesions of Libman–Sacks endocarditis. [91] However, there ...

Although the age of onset of lupus is typically between 15 and 44 years old, up to 25% of people diagnosed with systemic lupus erythematosus (SLE) have late-onset lupus. Lupus is most commonly ...

11 who reported radiographic skeletal involvement, attention has been focused on bone lesions in this disorder ... of gall-bladder opacification after oral administration of the dye.

In addition, 19 juvenile systemic sclerosis (jSSc) and 25 age-matched healthy children were selected as patient control and healthy control, respectively. Results Serum NF-κB levels in patients with ...

In the Phase 2b CARE study, the investigational drug, cenerimod, demonstrated safe and effective results for treatment of adults with moderate-to-severe systemic lupus erythematosus (SLE). The drug’s ...